Supporting Your INOMAX Reimbursement Needs
A 24/7/365 commitment to service
INOMAX reimbursement assessment and assistance
In the constantly changing and challenging managed care landscape, your NAM can provide Mallinckrodt’s understanding and perspective on local, regional, and national reimbursement trends.
Together with your finance and clinical teams, your NAM can assist with identifying current reimbursement strategies for INOMAX. You are ultimately responsible for determining the appropriate reimbursement strategies and billing codes.
Your NAM can work with you to facilitate periodic reviews to support your reimbursement strategies and processes.

Here for You When Reimbursement Challenges Arise
- CONTACT YOUR CRITICAL CARE BUSINESS MANAGER (CCBM) to discuss your challenge in more detail.
- ENGAGE KEY STAKEHOLDERS early in the process to identify the specific area of reimbursement concern.
- REVIEW 5 AREAS OF REIMBURSEMENT with your team to help determine the potential origin of your challenge. View more
- PREPARE FOR A PRODUCTIVE REIMBURSEMENT MEETING with your CCBM, NAM, and all key stakeholders. View more
5 areas of reimbursement focus
- Ensure prescribing HCPs are coding INOMAX as a drug, not a medical gas
- Confirm that the neonates’ diagnoses are appropriately documented to avoid any potential off-label concerns
- Verify that the order for INOMAX is correctly documented in patient charts and that the medical records department recognizes the order and uses the ICD-10 procedure code: 3EØF7SD
You are ultimately responsible for determining the appropriate reimbursement strategies and billing codes.
- Meet with purchasing/contracting/sourcing personnel to review contracts of primary payors to assess any specific clauses pertaining to high-cost pharmaceuticals and cost outliers
If these clauses exist…
- Identify the payor’s coding requirements to help support reimbursement.
- Identify who maintains the charge description master (CDM) at your institution, and determine how the charge is set up in the CDM
- Confirm all appropriate codes are entered into the chargemaster and that all charges associated with INOMAX are appropriately coded and captured
You are ultimately responsible for determining the appropriate reimbursement strategies and billing codes.
- Understand how INOMAX is addressed in your payor contracts—this is important. There may be special provisions to determine if your institution’s utilization is material and may warrant additional payments
- Consult with contracting/purchasing/sourcing personnel to help identify areas of opportunity and risk, and proactively address them through contract negotiations
- Work with purchasing/contracting/sourcing personnel to perform a retrospective analysis on the reimbursement history for INOMAX to determine whether contracted payment is being received
Preparing for a productive reimbursement meeting
- INVOLVE prescribing physicians, respiratory therapy director, and coding and billing
- INVOLVE contracting, purchasing, and sourcing
- INVOLVE revenue cycle review manager, coding and billing, respiratory therapy director, and pharmacy
Each key stakeholder has an important role in the INOMAX reimbursement process. It is imperative they are in attendance and prepared for the meeting with the NAM.
Optimal attendance is key to facilitating solutions identified during the meeting and developing an action plan.